Abstract
The levels of prealbumin (PAB, transthyretin) were determined and evaluated in the cerebrospinal fluid (CSF) and serum in various subgroups of the multiple sclerosis (MS) patients. In severely disabled patients, serum PAB was elevated more frequently. CSF and serum PAB concentrations were higher in treated than in nontreated patients; the values above the upper reference limits were also more frequently found in treated patients. PAB index showed a tendency to decrease during the course of the disease. The routine determination of PAB in CSF and serum is, therefore, recommended to be recognized in MS patients as a substantial clinical value and, thus, be comprised, including also immunoglobulins and other parameteres, into the spectrum of characteristics in Protein Pannel.
Similar content being viewed by others
Abbreviations
- Alb:
-
albumin
- CSF:
-
cerebrospinal fluid
- MS:
-
multiple sclerosis
- PAB:
-
prealbumin
References
Adam P., Kratochvíla J., Táborský L., Průcha M., Sobek O., Zeman D.: Cerebrospinal Fluid Cytology. Monograph on CD-ROM. Medica News Publishers, Prague 2000.
Adam P., Táborský L., Sobek O., Hildebrand T., Kelbich P., Průcha M., Hyánek J.: Cerebrospinal fluid. Adv.Clin.Chem. 36, 1–62 (2001).
Adam P., Sobek O., Táborský L.: Orosomucoid (α1-glycoprotein) levels in MS patients subgroups. Clin.Chim.Acta 334, 107–110 (2003a).
Adam P., Sobek O., Táborský L., Hildebrand T., Průcha M., Hyánek J., Žáček P., Veselá B.: Complete proteinogram of cerebrospinal fluid and its contribution to the diagnostics of inflammatory and autoimmune diseases of the central nervous system. 1st Fac.Med. Charles Univ. Quaterly J. (Sborník lékařský) 104, 1–12 (2003b).
Adam P., Táborský L., Sobek O, Kelbich P.: Cytology of Cerebrospinal Fluid. Medica News Publishers, Prague 2003c.
Adam P., Sobek O., Scott S.: Analysis of cerebrospinal fluid cell populations with monoclonal antibodies. Folia Microbiol. 52, 529–534 (2007).
Bednářová J., Štourač P.: Intrathecal synthesis of specific anti-Borrelia IgG antibodies and its role in diagnostics of neuroborreliosis. Klin.Biochem.Metab. 8, 219–223 (2000).
Bednářová J., Štourač P., Adam P.: The diagnostical relevance of immunological variables in neuroborreliosis and multiple sclerosis. Acta Neurol.Scand. 112, 97–102 (2005).
Deisenhammer F., Bartos A., Egg R., Gilhus N.E., Giovannoni G., Rauer S., Sellebjerg F.: Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur.J.Neurol. 13, 913–922 (2006).
Deisenhammer F., Bartos A., Egg R., Gilhus N.E., Giovannoni G., Rauer S., Sellebjerg F.: Replay to Sobek et al.: Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur.J.Neurol. 14, 15 (2007).
Felgenhauer K.: Laboratory diagnosis of neurological diseases, in L. Thomas (Ed.): Clinical Laboratory Diagnostics. Use and Assessment of Clinical Laboratory Results, 1st Engl. ed. TH-Books Verlagsgesellschaft mbH, Frankfurt/Main 1998.
Krzalic L.: Prealbumin content of cerebrospinal fluid and sera in persons with multiple sclerosis. Clin.Chim.Acta 124, 339–341 (1982).
Kurtzke J.F.: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 133, 1444–1452 (1983).
Lamoureux G., Jolicoeur R., Giard N., St-Hilaire M., Duplantis F.: Cerebrospinal fluid proteins in multiple sclerosis. Neurology 25, 537–546 (1975).
Larsen P.D., Delallo L.J.: Cerebrospinal fluid transthyretin in multiple sclerosis. Neurology 37, 1262–1263 (1987).
Lodin Z.: Inflammatory and autoimmune diseases of the nervous system: possibilities of laboratory diagnostic methods in cerebrospinal fluid. Folia Microbiol. 48, 839–847 (2003).
McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B.Y., Wolinsky J.S.: Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann.Neurol. 50, 121–127 (2001).
Reiber H., Thompson E.J., Grimsley G., Bernardi G., Adam P., Monteiro de Almeida S., Fredman P., Keir G., Lammers L., Liblau R., Menna-Barreto M., Sa M.J., Seres E., Sindic C.J.M., Teelken A., Trendelenburg C., Trojano M., van Antwerpen M., Verbeek M.M.: Quality assurance for cerebrospinal fluid analysis: international consensus by an internet-based group discussion. Clin.Chem.Lab.Med. 41, 331–337 (2003).
Sobek O., Adam P., Zeman D., Kelbich P., Tauberová A., Tyl D.: Cerebrospinal fluid parameters in patients with neuroborreliosis. Klin.Biochem.Metab. 6, 229–234 (1998).
Sobek O., Adam P., Táborský L., Zeman D., Kelbich P., Hildebrand T.: Protein fractions and other cerebrospinal fluid parameters in patients with multiple sclerosis. Klin.Biochem.Metab. 8, 209–212 (2000).
Sobek O., Adam P., Táborský L., Průcha M., Veselá B.: Acute and chronical forms of neuroborreliosis — cerebrospinal fluid differential diagnostics. Klin.Biochem.Metab. 10, 43–50 (2002).
Sobek O., Adam P.: Letter to the editors: On Seyfert S., Kunzmann V., Schwertfeger N., Koch H.C., Faulstich A.: Determinants of lumbar CSF protein concentration. J.Neurol. 250, 371–372 (2003).
Sobek O., Adam P., Svatoňová J.: Letter to the editors: On Deisenhammer F. et al.: Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur.J.Neurol. 14, 14 (2007).
Štourač P.: Oligoclonal synthesis of IgG in auto-immune neurological paraneoplastic syndromes. Klin.Biochem.Metab. 8, 224–228 (2000).
Štourač P., Bednářová J.: Intrathecal, antiviral and oligoclonal synthesis of IgG in multiple sclerosis and its role in differential diagnostics of neurological disease. Klin.Biochem.Metab. 8, 204–208 (2000).
Štourač P., Kadaňka Z., Palyza V.: Paraneoplastic neurological syndromes — patients’ cohort profile in the Czech Republic. Acta Neurol.Scand. 104, 72–77 (2001).
Svatoňová J.: Critical evaluation of the biological role of IgM in cerebrospinal fluid in inflammatory and other diseases of the nervous system. Folia Microbiol. 51, 485–491 (2006).
Zeman D., Adam P., Kalistová H., Sobek O., Kelbich P., Anděl J., Anděl M.: Transferrin in patients with multiple sclerosis: a comparison among various subgroups of multiple sclerosis patients. Acta Neurol.Scand. 101, 89–94 (2000).
Zeman D., Adam P., Kalistová H., Sobek O., Anděl J., Anděl M.: Cerebrospinal fluid cytological findings in multiple sclerosis: a comparison between patient subgroups. Acta Cytol. 45, 51–59 (2001).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hybeľová, M., Svatoňová, J., Sobek, O. et al. Cerebrospinal fluid and serum prealbumin (transthyretin) in patients with multiple sclerosis (MS): Comparison of particular subgroups of MS patients. Folia Microbiol 54, 173–176 (2009). https://doi.org/10.1007/s12223-009-0027-4
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12223-009-0027-4